Three Years of Erlotinib in Routine Practice for Non-small Cell Lung Cancer in South East Scotland

J. A. D. Ironside, J. F. English, G. R. Kerr, A. Price, F. A. Little, S. C. Erridge, M. J. Mackean

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Three Years of Erlotinib in Routine Practice for Non-small Cell Lung Cancer in South East Scotland'. Together they form a unique fingerprint.

Medicine & Life Sciences